Wells Fargo & Company »

Fulcrum Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-12-31 $161k 34k 4.70
2024-09-30 $91k 26k 3.57
2024-06-30 $156k 25k 6.20
2024-03-31 $3.7k 387 9.44
2023-12-31 $2.6k 381 6.75
2023-09-30 $1.6k 361 4.44
2023-06-30 $3.2k 965 3.30
2022-12-31 $23k 3.2k 7.28
2022-09-30 $65k 5.6k 11.63
2022-06-30 $29k 5.9k 4.88
2022-03-31 $332k 14k 23.63
2021-12-31 $404k 23k 17.69
2021-09-30 $164k 5.9k 28.01
2021-06-30 $83k 7.9k 10.52
2021-03-31 $111k 9.3k 11.85
2020-12-31 $221k 19k 11.73
2020-09-30 $117k 15k 7.89
2020-06-30 $280k 15k 18.27
2020-03-31 $109k 9.1k 11.98
2019-12-31 $33k 2.0k 16.77
2019-09-30 $2.0k 364 5.49